Bimiralisib (PQR309), 25mg

Bimiralisib (PQR309), 25mg

Bimiralisib (PQR309), 1g

Bimiralisib (PQR309), 1g

Bimiralisib (PQR309), 100mg

5.834,57 RON
SKU
SKM_S8738_100mg

Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTORinhibitor with in vitro and in vivo antilymphoma activity. It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets.

Mai multe informatii
Price 4.903,00 RON (preturile sunt fara TVA)
Description

Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTORinhibitor with in vitro and in vivo antilymphoma activity. It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets.